KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Acquisitions (2021 - 2024)

Cardlytics (CDLX) has disclosed Acquisitions for 3 consecutive years, with $202000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Acquisitions changed N/A year-over-year to $202000.0, compared with a TTM value of $202000.0 through Dec 2024, changed N/A, and an annual FY2022 reading of $2.3 million, down 99.54% over the prior year.
  • Acquisitions was $202000.0 for Q4 2024 at Cardlytics, down from $2.3 million in the prior quarter.
  • Across five years, Acquisitions topped out at $494.1 million in Q2 2021 and bottomed at $202000.0 in Q4 2024.
  • Average Acquisitions over 3 years is $161.3 million, with a median of $75.5 million recorded in 2021.
  • Peak annual rise in Acquisitions hit 98.47% in 2022, while the deepest fall reached 98.47% in 2022.
  • Year by year, Acquisitions stood at $494.1 million in 2021, then crashed by 99.54% to $2.3 million in 2022, then tumbled by 91.12% to $202000.0 in 2024.
  • Business Quant data shows Acquisitions for CDLX at $202000.0 in Q4 2024, $2.3 million in Q1 2022, and $494.1 million in Q2 2021.